Patterns of Neutropenia and Risk Factors for Febrile Neutropenia of Diffuse Large B-Cell Lymphoma Patients Treated with Rituximab-CHOP

Febrile neutropenia (FN) is the major toxicity of rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) regimen in the treatment of diffuse large B-cell lymphoma (DLBCL). The prediction of neutropenia and FN is mandatory to continue the planned R-CHOP therapy resulting i...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Yong Won, Jeong, Seong Hyun, Ahn, Mi Sun, Lee, Hyun Woo, Kang, Seok Yun, Choi, Jin-Hyuk, Jin, U Ram, Park, Joon Seong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4234916/
https://www.ncbi.nlm.nih.gov/pubmed/25408580
http://dx.doi.org/10.3346/jkms.2014.29.11.1493

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4234916/
https://www.ncbi.nlm.nih.gov/pubmed/25408580
http://dx.doi.org/10.3346/jkms.2014.29.11.1493

Ejemplares similares